anmelden
Swiss All Share Index
18.813,39
PKT
+22,25
PKT
+0,12
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 15.11.12 | Swiss Re kaufen | Hamburger Sparkasse AG (Haspa) | |
| 15.11.12 | Novartis buy | UBS AG | |
| 15.11.12 | Logitech equal-weight | Morgan Stanley | |
| 15.11.12 | Zurich Insurance neutral | Sarasin Research | |
| 15.11.12 | Zurich Insurance hold | Vontobel Research | |
| 15.11.12 | ABB (Asea Brown Boveri) buy | Vontobel Research | |
| 15.11.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 14.11.12 | Sonova neutral | UBS AG | |
| 14.11.12 | Sonova overweight | J.P. Morgan Cazenove | |
| 14.11.12 | Swiss Prime Site hold | Vontobel Research | |
| 14.11.12 | Geberit halten | Öko Invest | |
| 14.11.12 | Sonova underperform | Exane-BNP Paribas SA | |
| 14.11.12 | Swiss Life buy | Nomura | |
| 14.11.12 | Nestlé overweight | Morgan Stanley | |
| 14.11.12 | Swiss Prime Site buy | Sarasin Research | |
| 14.11.12 | PSP Swiss Property neutral | Sarasin Research | |
| 14.11.12 | Julius Bär buy | Sarasin Research | |
| 14.11.12 | Julius Bär reduce | Vontobel Research | |
| 14.11.12 | UBS overweight | Morgan Stanley | |
| 14.11.12 | Sonova buy | Vontobel Research | |
| 14.11.12 | Clariant buy | Vontobel Research | |
| 13.11.12 | Swiss Life buy | Vontobel Research | |
| 13.11.12 | Swisscom hold | Vontobel Research | |
| 13.11.12 | Sonova buy | Vontobel Research | |
| 13.11.12 | Swiss Life buy | Sarasin Research | |
| 13.11.12 | Sonova neutral | Sarasin Research | |
| 13.11.12 | PSP Swiss Property hold | Vontobel Research | |
| 12.11.12 | Novartis outperform | Credit Suisse Group | |
| 12.11.12 | Holcim hold | Deutsche Bank AG | |
| 12.11.12 | Swisscom neutral | Nomura | |
| 12.11.12 | Richemont buy | Nomura | |
| 12.11.12 | Avolta (ex Dufry) buy | Vontobel Research | |
| 12.11.12 | Sonova underperform | Exane-BNP Paribas SA | |
| 12.11.12 | Richemont buy | Vontobel Research | |
| 12.11.12 | Holcim outperform | Exane-BNP Paribas SA | |
| 12.11.12 | Swatch (I) buy | Vontobel Research | |
| 12.11.12 | Julius Bär reduce | Vontobel Research | |
| 12.11.12 | UBS outperform | Macquarie Research | |
| 09.11.12 | Swiss Re kaufen | Norddeutsche Landesbank (Nord/LB) | |
| 09.11.12 | Swiss Re buy | UBS AG |